LENZ Therapeutics, Inc. (LENZ)
NASDAQ · Healthcare
LENZ Therapeutics, Inc. EPS 2024–2025
LENZ Therapeutics, Inc. annual/quarterly eps history and growth rate from 2024 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- LENZ Therapeutics, Inc. eps for the quarter ending March 31, 2026 was $1.32, a 149.06% increase year-over-year.
- LENZ Therapeutics, Inc. annual eps for 2025 was $2.85, a 21.79% increase from 2024.
- LENZ Therapeutics, Inc. annual eps for 2024 was $2.34.
EPS
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
LENZ Therapeutics, Inc. EPS — FAQ
LENZ Therapeutics, Inc. (LENZ) eps over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is LENZ Therapeutics, Inc.'s eps?
LENZ Therapeutics, Inc. (LENZ) reported eps of $-2.85 for fiscal 2025.
Where can I see LENZ's eps history?
The chart and table above show LENZ Therapeutics, Inc.'s eps by year and by quarter, including the growth rate.